NCT04635735 Study of Ipilimumab After Stem Cell Transplantation in People With Relapsed/Refractory Multiple Myeloma Status TERMINATED Phase PHASE1/PHASE2
NCT04624178 A Study of Rucaparib and Nivolumab in People With Leiomyosarcoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04623801 Laser Ablation of Papillary Thyroid Microcarcinoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04577326 Mesothelin-targeted CAR T-cell Therapy in Patients With Mesothelioma Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT04577014 Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma Status RECRUITING Phase PHASE1/PHASE2
NCT04571229 Expanded Access Use of L-MTP-PE for the Treatment of Osteosarcoma Status AVAILABLE Phase N/A
NCT04569773 Choosing Ovarian Preservation or Removal Before Surgery for Endometrial Cancer Status ACTIVE_NOT_RECRUITING Phase N/A
NCT04566978 89Zr-DFO-REGN3767 in PET Scans in People With Diffuse Large B Cell Lymphoma (DLBCL) Status COMPLETED Phase EARLY_PHASE1
NCT04556266 A Phase I Trial of Donor- Derived 19-28z CAR T Cells Following Allogeneic Transplant for the Treatment of CD19 Malignancies Status WITHDRAWN Phase PHASE1
NCT04555551 MCARH109 Chimeric Antigen Receptor (CAR) Modified T Cells for the Treatment of Multiple Myeloma Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT04552990 Use of Jet-injection in Photodynamic Therapy for Basal Cell Carcinoma Status COMPLETED Phase PHASE2
NCT04552288 Study of Benralizumab in People With Skin Side Effects Caused by Cancer Therapies Status COMPLETED Phase PHASE2
NCT04544111 PDR001 Combination Therapy for Radioiodine-Refractory Thyroid Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04544098 Lutathera in People With Gastroenteropancreatic (GEP), Bronchial or Unknown Primary Neuroendocrine Tumors That Have Spread to the Liver Status ACTIVE_NOT_RECRUITING Phase EARLY_PHASE1
NCT04512716 Iomab-ACT: A Pilot Study of 131-I Apamistamab Followed by CD19-Targeted CAR T-Cell Therapy for Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia or Diffuse Large B-Cell Lymphoma Status RECRUITING Phase EARLY_PHASE1